Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AAM Urges Diverse Supply Chain To Mitigate Future Crises
Insists On Proactive Policy Response In Wake Of Coronavirus
Mar 30 2020
•
By
Akriti Seth
The AAM has urged supply chain diversification in order to tackle the COVID-19 crisis • Source: Shutterstock
More from Regulation
More from Policy & Regulation